Opportunities in Stem Cell Technology

Title	Published	Price
Monoclonal antibodies: 2009 update By: Datamonitor Introduction The report provides a comprehensive financial and strategic analysis of the mAb market, forecasting its commercial evolution out to 2014 and assessing trends by product, company, therapy area, geography, technology and target type. It also \| more...	11/2/2009	$7,600.00
Biotechnology (Pharmaceuticals) Report By: Plimsoll Publishing Ltd. The Global Biotechnology Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial evaluation \| more...	11/1/2009	$1,500.00
Biopharmaceuticals Industry Report By: Plimsoll Publishing Ltd. The Global Biopharmaceuticals Industry Report Plimsoll Publishing Ltd. Do you know.... The top 7 best trading partners in the industry? Which company has the highest sales growth? Which companies have the highest levels of debt? This report is an in-depth financial \| more...	11/1/2009	$1,500.00
Opportunities in Human Embryonic Stem Cell (hESC) Products By: BioInformant Worldwide, L.L.C. Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. They are the most pluripotent of all stem cell \| more... Search inside this report	11/1/2009	$3,495.00
Global Stem Cell and Advanced Technologies Market By: MarketsandMarkets The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and \| more... Search inside this report	11/1/2009	$4,650.00
Freedonia Focus on Biologicals By: Freedonia Focus This report discusses US biologicals demand for the years 2003 and 2008, with forecasts for 2013. Topics covered include market size, product and market segmentation, technological and product development, regulatory considerations, market environment, \| more...	10/31/2009	$500.00
H4-13, Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009 By: Decision Resources Introduction: The third quarter of 2009 saw a heated debate in the United States over healthcare reform, the publication of a report on a European investigation of the pharmaceutical industry, the election of new governments \| more...	10/28/2009	$2,250.00
Scientific Research & Development in the US - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research & Development in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, \| more... Search inside this report	10/17/2009	$825.00
Biotechnology in Australia - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Biotechnology in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business operating \| more... Search inside this report	10/17/2009	$810.00
Scientific Research in Australia - Industry Risk Rating Report By: IBISWorld Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Scientific Research in Australia industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of the business \| more... Search inside this report	10/17/2009	$810.00

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/22/2009 - 2